UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 100

of 'Clinical features, evaluation, and treatment of retroperitoneal soft tissue sarcoma'

100
TI
The management of retroperitoneal soft tissue sarcomas.
AU
Jenkins MP, Alvaranga JC, Thomas JM
SO
Eur J Cancer. 1996;32A(4):622.
 
Over a 5-year period, all retroperitoneal soft tissue sarcomas (119) referred to the Royal Marsden Hospital, London, U.K., were recorded prospectively on a database and managed with a consistent treatment policy. On multivariate analysis, the significant factors responsible for determining prognosis were grade and completeness of excision. Despite improvements in surgical clearance rates (nearly 50% completely excised in this series), the prognosis was poor with 2- and 5-year survival rates of 53 and 20%, respectively. Further improvements in survival rates will depend on better adjuvant treatment.
AD
Soft Tissue Sarcoma Unit, Royal Marsden Hospital, London, U.K.
PMID